Condition: Respiratory Tract Neoplasms · Thoracic Neoplasms · Neoplasms by Site · Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Low-dose CT (LDCT）can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.
This description comes directly from the study's public registry record.
Jianxing He, MD · 86-20-83337792 · drjianxing.he@gmail.com
Always discuss trial participation with your own doctor first.
| Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06988943